Cycurion, Inc.
Company snapshot
A consistent view of the latest supported company value and reported operating results.
Fundamental lens
Four transparent questions from retained financial evidence. Each result stands on its own; Grizzly Bulls does not combine them into a score, ranking, or recommendation.
Trailing-twelve-month net income is negative. As of 2026-06-30.
Trailing-twelve-month operating cash flow less capital expenditures is negative. As of 2026-06-30.
Reported current liabilities exceed reported current assets on the latest comparable retained balance sheet. As of 2026-06-30.
Comparable retained change history is not available through this reader.
How this lens works
Profitability uses only the sign of retained trailing-twelve-month net income. Cash generation uses only the sign of retained trailing-twelve-month free cash flow, defined as operating cash flow less capital expenditures.
Liquidity compares current assets with current liabilities only when both are retained for the same reporting date. It does not infer liquidity from differently dated balance sheets.
Recent operating direction uses the latest supported material financial event when comparable history exists. The existing change methodology requires at least a 10% absolute change or a sign/zero transition and compares quarterly results only with the same fiscal quarter year over year.
Market summary
Completed-session reference prices from IEX for Oct 16, 2026.
Price statistics
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history. Prices are unadjusted. Price returns exclude dividends and are not total returns. Historical statistics appear only when the retained source-session chain is complete and no split-like share-basis discontinuity is detected for that calculation window.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Price history
Recent completed-session closing-price history for this listing. The chart shows raw, unadjusted single-exchange reference observations rather than a consolidated U.S. market close.
Derived reference metrics are omitted for this listing because the required history-quality checks did not clear for the full retained window.
About this market data
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The raw chart can show a discontinuity around a stock split because it is intentionally unadjusted. The screened metrics use only explicitly registered positive split events and do not assert complete split history.
Listing & sources
Ticker: CYCU · Exchange: Nasdaq · Common stock, par value $0.0001 per share
SEC issuer CIK: 0001868419
Listing source refreshed: 2026-09-13
Financials
SEC-reported financial statement history with filing dates preserved. Annual view retains up to four fiscal years; quarterly view retains up to five fiscal quarters. Missing cells mean a supported fact is unknown and are not treated as zero.
Income statement
| Metric | TTM · 2026-06-30 | FY 2025 · 2025-12-31 | FY 2025 · 2024-12-31 | 2023-12-31 | FY 2023 · 2022-12-31 |
|---|---|---|---|---|---|
| Revenue | $14.4M Filed 2026-08-14 | $15.13M Filed 2026-03-31 | $17.77M Filed 2026-03-31 | $19.35M Filed 2025-04-17 | Unknown |
| Cost of revenue | $11.92M Filed 2026-08-14 | $13.52M Filed 2026-03-31 | $14.14M Filed 2026-03-31 | $16.71M Filed 2025-04-17 | Unknown |
| Gross profit | $2.48M Filed 2026-08-14 | $1.61M Filed 2026-03-31 | $3.63M Filed 2026-03-31 | $2.64M Filed 2025-04-17 | Unknown |
| Operating expenses | $16.29M Filed 2026-08-14 | $25.03M Filed 2026-03-31 | $1.22M Filed 2026-03-31 | Unknown | Unknown |
| Operating income | -$13.81M Filed 2026-08-14 | -$23.41M Filed 2026-03-31 | $2.42M Filed 2026-03-31 | $326,411 Filed 2025-04-17 | -$2.02M Filed 2024-04-26 |
| Pretax income | -$15.12M Filed 2026-08-14 | -$24.06M Filed 2026-03-31 | $1.23M Filed 2026-03-31 | -$2.09M Filed 2025-04-17 | -$450,186 Filed 2024-04-26 |
| Income tax expense | $0 Filed 2026-08-14 | $0 Filed 2026-03-31 | $0 Filed 2026-03-31 | $3,787 Filed 2025-04-17 | $250,739 Filed 2024-04-26 |
| Net income | -$14.11M Filed 2026-08-14 | -$23.67M Filed 2026-03-31 | $1.23M Filed 2026-03-31 | -$2.1M Filed 2025-04-17 | -$700,925 Filed 2024-04-26 |
| Diluted EPS | Unavailable | -$13.39 Filed 2026-03-31 | $1.66 Filed 2026-03-31 | -$0.14 Filed 2025-04-17 | Unknown |
| Diluted shares | Unavailable | 1.76M Filed 2026-03-31 | 904.93K Filed 2026-03-31 | 14.78M Filed 2025-04-17 | Unknown |
Balance sheet
| Metric | FY 2025 · 2025-12-31 | FY 2025 · 2024-12-31 | 2023-12-31 | FY 2023 · 2022-12-31 |
|---|---|---|---|---|
| Cash | $5.26M Filed 2026-03-31 | $38,742 Filed 2026-03-31 | $607,869 Filed 2025-04-17 | $809,481 Filed 2024-04-26 |
| Current assets | $8M Filed 2026-03-31 | $10.93M Filed 2026-03-31 | $8.41M Filed 2025-04-17 | $1.08M Filed 2024-04-26 |
| Current liabilities | $16.91M Filed 2026-03-31 | $18.74M Filed 2026-03-31 | $14.11M Filed 2025-04-17 | Unknown |
| Total assets | $33.45M Filed 2026-03-31 | $25.56M Filed 2026-03-31 | $20.8M Filed 2025-04-17 | $118.29M Filed 2024-04-26 |
| Total liabilities | $17.21M Filed 2026-03-31 | $20.18M Filed 2026-03-31 | $15.55M Filed 2025-04-17 | $1.24M Filed 2024-04-26 |
| Stockholders’ equity | $20.1M Filed 2026-03-31 | $3.47M Filed 2026-03-31 | $5.25M Filed 2025-04-17 | $5.02M Filed 2025-04-17 |
Cash flow
| Metric | TTM · 2026-06-30 | FY 2025 · 2025-12-31 | FY 2025 · 2024-12-31 | 2023-12-31 | FY 2023 · 2022-12-31 |
|---|---|---|---|---|---|
| Operating cash flow | -$11.96M Filed 2026-08-14 | -$12.09M Filed 2026-03-31 | -$1.37M Filed 2026-03-31 | -$1.99M Filed 2025-04-17 | -$1.32M Filed 2024-04-26 |
| Capital expenditures | $473,000 Filed 2026-08-14 | $455,000 Filed 2026-03-31 | $448,000 Filed 2026-03-31 | $12,774 Filed 2025-04-17 | Unknown |
| Stock repurchases | Unknown | $1M Filed 2026-03-31 | $0 Filed 2026-03-31 | $114.33M Filed 2024-04-26 | Unknown |
Calculated from the latest TTM financials
Source: SEC filings. Financial facts retain filing dates and are shown only when the retained source and period alignment support them.
Valuation
Reference valuation uses the latest retained completed-session IEX close and the latest supported SEC-reported share count for a simple single ordinary-share structure.
Open this stock in the Valuation Lab →
Shares outstanding: 25.84M · reported as of 2026-08-10 · filed 2026-08-14
The price is a source-scoped IEX reference close, not a consolidated U.S. market close. P/E and enterprise-value multiples are omitted unless compatible common-equity earnings and complete financing scope are established rather than inferred from adjacent statement fields.
Statistics
Reproducible trailing, quarterly, and annual statistics from retained SEC financials. Growth and return measures appear only when the required reporting periods align; missing denominators are omitted rather than estimated.
Trailing, quarterly, and annual profitability, return, and growth measures derived from retained SEC financials.
Latest annual liquidity measures using same-period reported current assets and current liabilities.
Trailing cash generation plus latest annual dividends and share repurchases where reported.
Historical financial statistics are descriptive accounting measures, not rankings or investment recommendations.
Ownership
No reviewed company-level insider ownership record is available for this listing.